http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-109829-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2017-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589e637640a348954dfd7929f1080661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fec48dbe44a05f0f0c3b39b8934bdb03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff5def3bdd3543b33ae974810aae831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_209259f9f93ce12923b6dae8f91c4a70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83413618aa6a15ca8b99b862f10a8ecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7355170c6d098bddca9c2c9000f03f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460568d681d40c750e4ce49eaf023df1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6be8cc84d79459d55ea96bb08b929e
publicationDate 2019-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-109829-A1
titleOfInvention BRIDGED PIPERIDINE DERIVATIVES
abstract This refers to a compound of formula (1), in which: R¹ is hydrogen, lower alkyl, lower alkyl substituted by halogen, halogen, lower alkoxy or lower alkoxy substituted by halogen, R¹ may be the same or different in the case that n = 2 or 3; n is 1, 2 or 3; m is 1, 2 or 3; Ar is a five or six element heteroaryl group, selected from among the compounds of the group of formulas (2), in which: R² is hydrogen, lower alkyl, lower alkyl substituted by halogen, halogen or lower alkoxy; R³ is hydrogen or halogen; - () ₘ- is - (CH₂) ₘ-; or to pharmaceutically active acid addition salts thereof. The compounds can be used for the treatment of Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with Dutch amyloidosis (HCHWA-D), multi-infarcted dementia, pugilistic dementia or Down syndrome.
priorityDate 2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 28.